Shanghai Fosun Pharmaceutical (Group) (SFOSF) Projected to Post Earnings on Wednesday

Shanghai Fosun Pharmaceutical (Group) (OTCMKTS:SFOSF) is expected to be issuing its results after the market closes on Wednesday, August 26th. Analysts expect Shanghai Fosun Pharmaceutical (Group) to post earnings of $0.0416 per share and revenue of $1.6103 billion for the quarter.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

SFOSF opened at $2.20 on Monday. The company has a 50 day simple moving average of $2.11 and a two-hundred day simple moving average of $2.36. Shanghai Fosun Pharmaceutical has a 1-year low of $1.95 and a 1-year high of $3.50.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.